Market Tracker

09/01 1:05pm ET

Rexahn Pharmaceuticals Inc (NYSE MKT LLC:RNN)

0.70
Data as of Aug 29
 0.00 / 0.00%
Today’s Change
0.36
Today|||52-Week Range
1.85
+37.25%
Year-to-Date
No recent news for Rexahn Pharmaceuticals Inc.

Today’s Trading

Previous close0.70
Today’s open0.69
Day’s range0.69 - 0.71
Volume454,882
Average volume (3 months)1,083,106
Market cap$124.8M
Dividend yield--
Data as of 4:00pm ET, 08/29/2014

Growth & Valuation

Earnings growth (last year)-16.67%
Earnings growth (this year)-61.90%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book8.13

Competitors

 Today’s
change
Today’s
% change
EVARLombard Medical Inc+1.18+18.15%
LPCNLipocine Inc+0.75+8.44%
EPRSEPIRUS Biopharmaceut...-0.02-0.22%
RLMDRelmada Therapeutics...0.000.00%
Data as of 3:59pm ET, 08/29/2014

Financials

Next reporting dateDecember 3, 2014
EPS forecast (this quarter)-$0.02
Annual revenue (last year)$0.00
Annual profit (last year)-$9.5M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Scientist
Chang Ho Ahn
Chief Executive Officer &
Director
Peter David Suzdak
Corporate headquarters
Rockville, Maryland

Forecasts